Data Trace Publishing Company
P.O. Box 1230
Brooklandville, Maryland 21022-9978
In publishing this program, neither the author nor the publisher is engaged in rendering legal, medical, or other professional service. If legal advice or other expert assistance is required, please call your medical malpractice carrier’s risk management department.
Data Trace Publishing Company Continuing Education Mission Statement
Data Trace Publishing Company is committed to providing high-quality print and internet-based enduring continuing education programs, including case studies, feature articles, lectures and review articles on current clinical podiatric topics and medical risk management topics which lead to improved delivery of patient care and help reduce the potential for medical errors. These programs are provided to meet the educational needs of the podiatric medical profession and thereby enhance the quality of patient care.
To provide participants with an unbiased educational experience that will improve their understanding of risk management principles so that those principles can be applied in their practice.
To provide participants with an in-depth exposure to current trends in legal allegations made against podiatric physicians which illustrate breaches in the standard of care.
To provide participants with an opportunity to be exposed to educational tools that will help ensure patient safety within their practice.
After completing the DT Podiatric Risk Management instructional media program, the learner should be better able to devise and refine a perspective on current treatment recommendations, updates, and advances pertinent to podiatric practice; evaluate the implications of the learned information as it pertains to patient factors that contribute to poor outcomes and formulate strategies to prevent them; and apply current trends, standards, and best practices into the learner’s own practice.
Data Trace Publishing Company Continuing Education Accreditation Statement
Data Trace Publishing Company is approved by the Council on Podiatric Medical Education (CPME) as a provider of continuing education in podiatric medicine. Data Trace Publishing Company has approved this activity for a maximum of 6 continuing education contact hours (CECHs). Physicians should claim only the contact hours commensurate with the extent of their participation in the activity.
Estimated time to complete activity: 6 hours Date of release: January 1, 2023 Expiration Date: December 31, 2025 (unless further validated and extended by provider). For amended dates of activity expiration, please see DT Podiatric Risk Management Course Activity Effective Dates at www.datatrace.com).
No commercial interest provided financial support for this continuing education activity.
Participants of DT Podiatric Risk Management Course—Volume 5 will receive a maximum of 6 CECHs for a correctly-completed CME Answer Form. In order to qualify for CECHs, a score of 80% or more must be achieved on the written examination material. You will be responsible for notifying your state of the number of contact hours you have received.
Participants are also requested to complete a course evaluation for use in developing future issues and to meet the unique educational needs of podiatric physicians.
FINANCIAL DISCLOSURE INFORMATION
It is the policy of Data Trace Publishing Company to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty, presenters, speakers, authors, and reviewers participating in any programs provided by Data Trace Publishing Company are expected to disclose any relevant financial relationships with CPME-defined commercial interests to the program audience. “Relevant financial relationships” are financial relationships of the individual (including those of the individual’s spouse or partner) in any amount occurring within the past 12 months that create a conflict of interest. A commercial interest is any organization manufacturing, producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients. The CPME mandates that the content of accredited activities be objective and independent of commercial bias. The intent of this policy is that readers may form their own judgements about the presentations, using independent review to resolve all identified conflicts of interest.
In addition to disclosing commercial relationships, faculty are advised of the following policies:
Each continuing education planner and author has submitted a Conflict of Interest Disclosure in order to identify relevant financial relationships and resolve conflicts.
Limitations on Data: Presenter will ensure, to the extent possible, meaningful disclosure of limitations on data (e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion).
Discussion of Unapproved Uses: If unapproved (unlabeled) uses are discussed during the continuing education activity, the presenter will disclose when a product is not approved in the United States (and/or the nation where the activity takes place) for the use under discussion.
Data Trace Publishing Company has identified the option to disclose as follows:
The following authors have disclosed whether they or a member of their immediate family:
Will be receiving an honorarium for this activity
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they willrefer as speaker or author:
Received monetary or other significant research support
Are or had been a paid consultant
Are or had been a full-time or part-time employee
Are or had been a paid or unpaid member of an advisory or similar board
Are or had been a member or on the Board of Trustees
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, BUT will not be recommending any of their products over similar competitor products
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they willrefer as speaker or author, AND will be recommending one or more of their products over similar competitor products. Recommendation will be based on:
Exclusively on data and/or clinical experience not generated by the manufacturer or derived from manufacturer-sponsored studies
Data and/or clinical experience most of which were not generated by the manufacturer or derived from manufacturer-sponsored studies
Data and/or clinical experience, most of which were generated by the manufacturer or derived from manufacturer-sponsored studies
Exclusively on data and/or clinical experience generated by the manufacturer or derived from manufacturer or derived from manufacturer-sponsored studies